1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2016 Emerging Opportunities in the UK Infectious Disease Molecular Diagnostics Market: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review (DataPack)

This DataPack contains tables from VPGMarketResearch.com new report, "2016 Emerging Opportunities in the UK Infectious Disease Molecular Diagnostics Market: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review.”

For pricing information on DataPack sections or individual tables, please contact Customer Service.

Table Of Contents

2016 Emerging Opportunities in the UK Infectious Disease Molecular Diagnostics Market: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review (DataPack)
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests

Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
U.S.A.
Molecular Diagnostics Test Volume And Sales
by Major Application 2014-2019
U.S.A.
Laboratories Performing DNA Sequencing
by Market Segment 2014

U.S.A.
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
U.S.A.
Molecular Diagnostics Test Volume
by Major Application 2014-2019
U.S.A.
Major Infectious Disease Test Volume by Assay 2014-2019
U.S.A.
Major Infectious Disease Test Volume by Method 2014
U.S.A.
Molecular Diagnostics Market
by Major Application 2014-2019
U.S.A.
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
U.S.A.
Major Infectious Disease Diagnostics Market by Assay 2014-2019
U.S.A.
AIDS Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Adenovirus Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Chlamydia Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
CMV Testing Market
Estimated Sales by Major Supplier 2014

U.S.A.
Echovirus Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Enterovirus Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
EBV Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
U.S.A.
Herpes Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Influenza Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014

U.S.A.
Pneumonia Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Rabies Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
RSV Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Salmonella Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Shigella Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
West Nile Virus Nat Market
Reagent Sales by Major Supplier 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Forecast in the US

  • February 2017
    2 pages
  • Diagnostics  

    Cancer  

    Health Care Pro...  

  • United States  

View report >

The future of the Clinical Trial Industry in the US

  • January 2017
    2 pages
  • Clinical Trial  

    Genome Sequenci...  

    Biopsy  

  • United States  

View report >

Diagnostics Market Forecast in the US

  • January 2017
  • Diagnostics  

  • United States  

View report >

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.